AdsVEGF-D Delta N Delta C, Placebo to AdsVEGF-D Delta N Delta C test product clinical trials

Clinical development and proof of principle testing of new regenerative VEGF-D therapy for cost-effective treatment of refractory angina. A phase II randomized, double-blinded, placebo-controlled study.

This study is testing a new treatment called VEGF-D for severe chest pain (refractory angina). It aims to see if this treatment can help people walk further and feel better, compared to a dummy treatment.